FDA Executive Officer of Countermeasures Speaks Frankly About Vaccine Approval
Christopher Cole appears to be falling into a Project Veritas Honey Trap
With 2022 getting long in the tooth, I reviewed some stories that I bookmarked as the most entertaining of the year. This conversation, secretly recorded on January 21, 2021 by a Project Veritas reporter, was definitely in the top five.
Christopher Cole, who claimed to be an FDA Executive Officer of Countermeasures Initiative, seems keen to to demonstrate all of the special, insider information he possesses about the recent EUA for the new COVID-19 vaccines. He has something intriguing to say, and he knows about it because of his special, privileged position.
I wasn’t surprised to hear that his table companion’s voice is that of a woman—probably a young one. Mr. Cole has that distinct look that men get when they are mesmerized by a woman and want to impress her. In short, this FDA Executive Officer appears to be falling into a Honey Trap.
For those unfamiliar with the term, “honey trapping” is a method of obtaining information by means of romantic seduction. The technique was probably used most effectively by the KGB during the Cold War for obtaining information from foreign officials. Vienna was apparently full of honey traps. American officials in the city were cautioned: “If it seems too good to be true that such a young and beautiful girl is attracted to an old guy like you, that’s because it is.”
The 6:30 minute tape is worth watching in full. In just a few minutes, Mr. Cole says pretty much everything we’ve long suspected about the FDA’s cozy relationship with the drug companies it is supposed to be regulating, and the financial incentives for approving their new products. Some of the nuggets he so eagerly offers:
There’s almost a billion dollars a year going into FDA’s budget from the people we regulate … The drug companies, the food companies, the vaccine companies, they pay us hundreds of millions of dollars a year to hire and keep the reviewers to approve their products.
If they can get every person required to get an annual vaccine, that is a recurring return of money going into their company.
I don’t completely agree with [the FDA’s [process [for authorizing COVID vaccines for children as young as six months]. All the tests aren’t there. I agree with the thing that it is important to inoculate them. But you can’t provide the parents as much assurity as you normally want to.
If Mr. Cole were to ask me for advice, I would tell him either to lose the undershirt or wear a tie.